Home
RAPT
RAPT News

Latest RAPT Therapeutics Inc. (RAPT) News on December 18, 2024

MT Newswires

a month ago

Stifel Nicolaus Downgrades RAPT Therapeutics to Hold From Buy, Cuts Price Target to $2 From $7

RAPT Therapeutics Reports Third Quarter 2024 Financial Results

GlobeNewswire

a month ago

RAPT Therapeutics Reports Third Quarter 2024 Financial Results

MT Newswires

a month ago

Top Midday Decliners

MT Newswires

a month ago

JPMorgan Downgrades RAPT Therapeutics to Underweight From Neutral; Shares Plunge

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull

Clinical Trials Arena

a month ago

RAPT Therapeutics shares tumble by 48% after zelnecirnon programme cull

MT Newswires

a month ago

RAPT Therapeutics Ends Zelnecirnon Program After FDA Hold on Trials

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

GlobeNewswire

a month ago

Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky

Simply Wall St.

a month ago

Companies Like RAPT Therapeutics (NASDAQ:RAPT) Could Be Quite Risky

RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now

Insider Monkey

3 months ago

RAPT Therapeutics, Inc. (RAPT): Worst 52-Week Low Stock to Buy Now

RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability

Insider Monkey

3 months ago

RAPT Therapeutics, Inc. (RAPT) Stock Falls Following FDA Setback; Short Sellers Cite Unprofitability

RAPT Therapeutics Reports Second Quarter 2024 Financial Results

GlobeNewswire

4 months ago

RAPT Therapeutics Reports Second Quarter 2024 Financial Results

MT Newswires

5 months ago

RAPT Therapeutics to Cut 40% Workforce -- Shares Down

Should You Sell Your Stake in RAPT Therapeutics (RAPT)?

Insider Monkey

6 months ago

Should You Sell Your Stake in RAPT Therapeutics (RAPT)?

Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround

Zacks

6 months ago

Down -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround

Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

7 months ago

Rapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

MT Newswires

7 months ago

Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform

Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks

Zacks

7 months ago

Here's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks

Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation

Simply Wall St.

7 months ago

Here's Why We're Watching RAPT Therapeutics' (NASDAQ:RAPT) Cash Burn Situation

GuruFocus.com

7 months ago

RAPT Therapeutics Inc. Reports Q1 2024 Earnings: A Detailed Financial Overview

MT Newswires

7 months ago

Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy

MT Newswires

7 months ago

Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?

Benzinga

7 months ago

What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?

MT Newswires

7 months ago

Sector Update: Health Care Stocks Higher Late Afternoon

MT Newswires

7 months ago

RAPT Therapeutics Shares Plunge After Wider Q1 Loss, Closing of Zelnecirnon Trials

RAPT Therapeutics Reports First Quarter 2024 Financial Results

GlobeNewswire

7 months ago

RAPT Therapeutics Reports First Quarter 2024 Financial Results

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

GlobeNewswire

8 months ago

RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients

What Makes RAPT Therapeutics (RAPT) an Investment Choice?

Insider Monkey

9 months ago

What Makes RAPT Therapeutics (RAPT) an Investment Choice?

Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings?

Zacks

9 months ago

Should You Buy RAPT Therapeutics (RAPT) Ahead of Earnings?

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire

9 months ago

RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire

9 months ago

RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting

Insider Buyers Lose Additional US$63k As RAPT Therapeutics Dips To US$236m

Simply Wall St.

10 months ago

Insider Buyers Lose Additional US$63k As RAPT Therapeutics Dips To US$236m

Rapt Therapeutics Crashes 74% After Unexpected Liver Failure Sidelines Two Tests

Investor's Business Daily

10 months ago

Rapt Therapeutics Crashes 74% After Unexpected Liver Failure Sidelines Two Tests

RAPT Therapeutics Stock Is Down 64%. FDA Halts 2 Studies After Liver Failure.

Barrons.com

10 months ago

RAPT Therapeutics Stock Is Down 64%. FDA Halts 2 Studies After Liver Failure.

Reuters

10 months ago

UPDATE 1-FDA puts on hold two Rapt Therapeutics mid-stage drug trials

Reuters

10 months ago

RAPT Therapeutics says FDA puts two mid-stage trials of company's drug on hold

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon

GlobeNewswire

10 months ago

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon

FDA puts hold on Rapt trials of drug for eczema, asthma

BioPharma Dive

10 months ago

FDA puts hold on Rapt trials of drug for eczema, asthma

RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vice President of Technical Operations

GlobeNewswire

10 months ago

RAPT Therapeutics Bolsters Leadership Team with the Appointment of Nipun Davar, Ph.D., as Senior Vice President of Technical Operations

RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

a year ago

RAPT Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Is It Too Late to Buy Tilray Brands Stock?

Motley Fool

a year ago

Is It Too Late to Buy Tilray Brands Stock?

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/30/2024

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 01/29/2024

Johnson & Johnson Faces a 1.03% Portfolio Impact in Eaton Vance Worldwide Health Sciences ...

GuruFocus.com

a year ago

Johnson & Johnson Faces a 1.03% Portfolio Impact in Eaton Vance Worldwide Health Sciences ...

Bel Fuse (BELFB) Declines More Than Market: Some Information for Investors

Zacks

a year ago

Bel Fuse (BELFB) Declines More Than Market: Some Information for Investors

Can This $100 Billion Cybersecurity Stock Help You Retire a Millionaire?

Motley Fool

a year ago

Can This $100 Billion Cybersecurity Stock Help You Retire a Millionaire?

GuruFocus.com

a year ago

Hilltop Holdings Inc (HTH) Reports Mixed Financial Results for Q4 and Full Year 2023

Associated Press Finance

a year ago

Hilltop Holdings: Q4 Earnings Snapshot

Business Wire

a year ago

Hilltop Holdings Inc. Announces Financial Results for Fourth Quarter and Full Year 2023

Should Value Investors Buy Assurant (AIZ) Stock?

Zacks

a year ago

Should Value Investors Buy Assurant (AIZ) Stock?

Kaplan Survey: Law Schools Concerned about Class Diversity, Amid Affirmative Action Ban Fallout

Business Wire

a year ago

Kaplan Survey: Law Schools Concerned about Class Diversity, Amid Affirmative Action Ban Fallout

Eaton Vance Tax-mangd Glo Buy-write Oppo's Dividend Analysis

GuruFocus.com

a year ago

Eaton Vance Tax-mangd Glo Buy-write Oppo's Dividend Analysis

Q3 Household Products Earnings Review: First Prize Goes to Clorox (NYSE:CLX)

StockStory

a year ago

Q3 Household Products Earnings Review: First Prize Goes to Clorox (NYSE:CLX)

Business Wire

a year ago

The New York Times Company to Announce Fourth-Quarter and Full-Year 2023 Financial Results on February 7, 2024

Bel Announces a New President of the Power and Protection Segment

GlobeNewswire

a year ago

Bel Announces a New President of the Power and Protection Segment

Are Consumer Staples Stocks Lagging Coca-Cola Europacific Partners (CCEP) This Year?

Zacks

a year ago

Are Consumer Staples Stocks Lagging Coca-Cola Europacific Partners (CCEP) This Year?

Canada Goose Stock (NYSE:GOOS): Benefit from Luxury Industry Panic

TipRanks

a year ago

Canada Goose Stock (NYSE:GOOS): Benefit from Luxury Industry Panic

Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?

Zacks

a year ago

Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Zacks

a year ago

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Caleres Reiterates Full Year 2023 Outlook

Business Wire

a year ago

Caleres Reiterates Full Year 2023 Outlook

MercadoLibre (NASDAQ:MELI) Q3 Earnings: Leading The Online Marketplace Pack

StockStory

a year ago

MercadoLibre (NASDAQ:MELI) Q3 Earnings: Leading The Online Marketplace Pack

RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

3 Charts For Investors to Watch Friday: Alphabet, Tesla, Altice USA

Investopedia

a year ago

3 Charts For Investors to Watch Friday: Alphabet, Tesla, Altice USA

Here’s Why ZipRecruiter (ZIP) Declined in Q3

Insider Monkey

a year ago

Here’s Why ZipRecruiter (ZIP) Declined in Q3

TELUS (TSE:T) shareholders have endured a 7.7% loss from investing in the stock a year ago

Simply Wall St.

a year ago

TELUS (TSE:T) shareholders have endured a 7.7% loss from investing in the stock a year ago

OFG Bancorp (NYSE:OFG) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Simply Wall St.

a year ago

OFG Bancorp (NYSE:OFG) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Gogo Business Aviation's 5G Program Achieves Key Milestones

PR Newswire

a year ago

Gogo Business Aviation's 5G Program Achieves Key Milestones

RLJ Lodging Trust Announces Dividends for Fourth Quarter of 2023

Business Wire

a year ago

RLJ Lodging Trust Announces Dividends for Fourth Quarter of 2023

Ready Capital Corporation Declares Fourth Quarter 2023 Dividends

GlobeNewswire

a year ago

Ready Capital Corporation Declares Fourth Quarter 2023 Dividends

Connection Achieves Microsoft Azure Expert MSP Renewal

Business Wire

a year ago

Connection Achieves Microsoft Azure Expert MSP Renewal

Centerra Gold Inc.'s (TSE:CG) institutional investors lost 7.2% last week but have benefitted from longer-term gains

Simply Wall St.

a year ago

Centerra Gold Inc.'s (TSE:CG) institutional investors lost 7.2% last week but have benefitted from longer-term gains

Lucid CFO resigns: Impact on stock, company outlook

Yahoo Finance Video

a year ago

Lucid CFO resigns: Impact on stock, company outlook

Those who invested in AGCO (NYSE:AGCO) five years ago are up 145%

Simply Wall St.

a year ago

Those who invested in AGCO (NYSE:AGCO) five years ago are up 145%

Oxford Industries, Inc. (NYSE:OXM) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Oxford Industries, Inc. (NYSE:OXM) Q3 2023 Earnings Call Transcript

Adams Natural Resources Fund Announces $19.96 Issue Price of Shares for Year-End Distribution Payable December 15, 2023

GlobeNewswire

a year ago

Adams Natural Resources Fund Announces $19.96 Issue Price of Shares for Year-End Distribution Payable December 15, 2023

Oman's BankDhofar is the First Bank in the Middle East to Install Diebold Nixdorf's RM4V Cash Recycling Engine to Deliver a World-Class Customer Experience

PR Newswire

a year ago

Oman's BankDhofar is the First Bank in the Middle East to Install Diebold Nixdorf's RM4V Cash Recycling Engine to Deliver a World-Class Customer Experience

Should You Invest in Natural Resource Partners L.P. (NRP)?

Insider Monkey

a year ago

Should You Invest in Natural Resource Partners L.P. (NRP)?

Capital Product Partners L.P. Announces Commencement of Rights Offering

GlobeNewswire

a year ago

Capital Product Partners L.P. Announces Commencement of Rights Offering

RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy

GlobeNewswire

a year ago

RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

InvestorPlace

a year ago

Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare

RAPT Therapeutics Inc Reports Increased R&D Expenses Amid Progress in Clinical Trials

GuruFocus.com

a year ago

RAPT Therapeutics Inc Reports Increased R&D Expenses Amid Progress in Clinical Trials

Capital Product Partners L.P. (NASDAQ:CPLP) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Capital Product Partners L.P. (NASDAQ:CPLP) Q3 2023 Earnings Call Transcript

Vital Energy Promotes Katie Hill to Senior Vice President and Chief Operating Officer

GlobeNewswire

a year ago

Vital Energy Promotes Katie Hill to Senior Vice President and Chief Operating Officer

Westrock Coffee Company to Participate in the Stephens Annual Investment Conference

GlobeNewswire

a year ago

Westrock Coffee Company to Participate in the Stephens Annual Investment Conference

RAPT Therapeutics Reports Third Quarter 2023 Financial Results

GlobeNewswire

a year ago

RAPT Therapeutics Reports Third Quarter 2023 Financial Results

TriNet Releases 2023 Environmental, Social and Governance Report

PR Newswire

a year ago

TriNet Releases 2023 Environmental, Social and Governance Report

WK Kellogg Co Announces Third Quarter 2023 Financial Results and Reaffirms Financial Outlook

PR Newswire

a year ago

WK Kellogg Co Announces Third Quarter 2023 Financial Results and Reaffirms Financial Outlook

TDCX Inc. to Report Third Quarter 2023 Results

Business Wire

a year ago

TDCX Inc. to Report Third Quarter 2023 Results

Thomson Reuters StreetEvents

a year ago

Q3 2023 Distribution Solutions Group Inc Earnings Call

WK Kellogg Co Declares Quarterly Dividend of $0.16 per Share

PR Newswire

a year ago

WK Kellogg Co Declares Quarterly Dividend of $0.16 per Share

Could The Market Be Wrong About CSW Industrials, Inc. (NASDAQ:CSWI) Given Its Attractive Financial Prospects?

Simply Wall St.

a year ago

Could The Market Be Wrong About CSW Industrials, Inc. (NASDAQ:CSWI) Given Its Attractive Financial Prospects?

Share on Social Networks: